ASCO Licensing Opportunities

ASCO Meeting Library ASCO eLearning ASCO -SEP Cancer.net ASCO Direct ASCO Seminars ASCO Journals ASCO Meeting Publications Journal of Clinical Oncology (JCO) serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. JCO strives to publish the highest quality articles dedicated to clinical research. Original reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, Guidelines, and other works that relate to the care of patients with cancer. Published three times a month, a total of 36 issues a year. JCO Oncology Practice (JCO OP) offers a mix of cancer care delivery research and reviews with a clinical focus. Published monthly, JCO OP also addresses an expressed need of practicing physicians to have compressed, expert opinions addressing common clinical problems. JCO Global Oncology (JCO GO) is an online- only, peer-reviewed, open access journal. The journal focuses on the unique challenges of cancer care and research facing resource- constrained countries to raise awareness, increase early detection and prevention, and improve end of life care. LICENSING OPPORTUNITIES Article Reprints and ePrints Reprints and ePrints in English or translation are available as soon as articles are posted online as ‘Early Release’. ePrints and reprints can be accompanied by the coordinating ASCO journal cover, showcasing that the articles are original and official ASCO licensed materials. Meeting Abstracts In addition to reprints and ePrints, Springer Healthcare has priority access to ASCO Annual Meeting and Symposia abstracts published as supplements to JCO. Guidelines ASCO Guidelines, published in JCO and JCO OP, are accompanied by summary slide sets, flow sheets, and decision aids that help to more widely disseminate the recommendations. Multimedia from ASCO Journals JCO’s Understanding the Pathway videos animate a pathway or biological process outlined in a related JCO article, and ASCO Journal Oncographics use infographics to summarize the key results from accompanying clinical trial articles. Themed Collections Also available, create a custom collection tailored to specific themes, drug classes, or compounds, with articles selected by local experts or with ASCO’s input. JCO Clinical Cancer Informatics (JCO CCI) is an interdisciplinary and borderless journal publishing clinically relevant research based on biomedical informatics methods and processes applied to cancer-related data, information, and images. ascopubs.org Volume38, Issue1 FeaturedContent: Biology of Neoplasia Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study K. Draaisma et al January1,2020 Pembrolizumab inNoncolorectalMSI-H/dMMR Cancer. A.Marabelle et al Pembrolizumab inMSI-HStage IVColorectal Cancer. D.T. Le et al Pembrolizumab inRelapsedMycosisFungoides andSézarySyndrome. M.S.Khodadoust et al Exercise Tolerance andMortality inChildhood CancerSurvivors. K.K.Ness et al GPR161 -AssociatedMedulloblastoma M.Begemann et al Atezolizumab andBevacizumab inVariantRenal CellCarcinomaHistology. B.A.McGregor et al Immunotherapy inAdrenocorticalCarcinoma N.Raj et al JCO Precision Oncology (JCO PO) publishes research that will advance the science and practice of precision oncology and define genomics-driven clinical care of patients with cancer. The journal provides a deeper understanding of actionable cancer genomics, personalized translational and clinical oncology research, and recent treatment advances based on tumor molecular profiling. Content Licensing Solutions • asco@springer.com 5